Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Development of Fluorescently Labeled Self-Emulsifying Drug Delivery Systems (SEDDS) for Prolonged Stability, In Vitro Sustained Release, and Cellular Uptake

View through CrossRef
Aim: In this study, four fluorescein hydrophobic ionic complexes were formed with the cationic polymers Eudragit RS, Eudragit RL, Eudragit E, and polyethyleneimine (PEI) to provide fluorescein sustained release, sustained cellular uptake, and stability. Methods: Complexes were loaded in a self-emulsifying drug delivery system (SEDDS) composed of 40% Tween 80, 20% Kolliphor EL, 15% 2-n-Octyl-1-dodecanol, and 25% dipropylene glycol. SEDDS were investigated regarding their size, polydispersity index (PDI), zeta potential, and cytotoxicity. Fluorescein release from SEDDS was performed in phosphate buffer (pH 6.8 and pH 8), and the released fluorescein was evaluated for cellular uptake. Moreover, fluorescein from all of the SEDDS pre-concentrates was released at different time points to check its long-term stability over six months. Results: The average fluorescein load in SEDDS was 0.045%. SEDDS showed an average droplet size of 24.9 ± 1.6 nm with PDI ≤ 0.3. SEDDS complexes diluted 1:100 increased the zeta potential from -7.3 mV to +3.7 mV and provided > 85% cell viability. A 92.27 ± 3.18% fluorescein exhibited a few seconds of immediate release when used as control or PEI complex in SEDDS. On the contrary, Eudragit-fluorescein complexes in SEDDS showed sustained release of 87.01 ± 5.22% fluorescein in ≤ 70 min with 22.19 ± 14.56% and 59.27 ± 16.57% released at 10 min in pH 6.8 and pH 8 release media, respectively. Comparatively, the medium at pH 6.8 maintained a significantly improved sustained fluorescein release (p ≤ 0.001). Furthermore, Eudragit RS/RL compared to Eudragit E, significantly exhibited a slower fluorescein release rate from SEDDS (p ≤ 0.01). The cellular uptake of the released fluorescein was 72.4 ± 8.2% for all SEDDS complexes after 3 h. Eudragit complexes compared to PEI complex in SEDDS significantly showed m ore sustained fluorescein cellular uptake at 1 h and 2 h (p ≤ 0.001). However, SEDDS complexes showed the longest fluorescein stability with PEI after six months, whereas fluorescein stability for SEDDS containing fluorescein as Eudragit complex and control showed 39.1% and 82.5% fluorescence decrease, respectively, after three months. Conclusion: In the developed SEDDS, the presence of hydrophobic ionic complexes can significantly promote longer stability and sustained cellular uptake of fluorescein while releasing in a sustained manner.
Title: Development of Fluorescently Labeled Self-Emulsifying Drug Delivery Systems (SEDDS) for Prolonged Stability, In Vitro Sustained Release, and Cellular Uptake
Description:
Aim: In this study, four fluorescein hydrophobic ionic complexes were formed with the cationic polymers Eudragit RS, Eudragit RL, Eudragit E, and polyethyleneimine (PEI) to provide fluorescein sustained release, sustained cellular uptake, and stability.
Methods: Complexes were loaded in a self-emulsifying drug delivery system (SEDDS) composed of 40% Tween 80, 20% Kolliphor EL, 15% 2-n-Octyl-1-dodecanol, and 25% dipropylene glycol.
SEDDS were investigated regarding their size, polydispersity index (PDI), zeta potential, and cytotoxicity.
Fluorescein release from SEDDS was performed in phosphate buffer (pH 6.
8 and pH 8), and the released fluorescein was evaluated for cellular uptake.
Moreover, fluorescein from all of the SEDDS pre-concentrates was released at different time points to check its long-term stability over six months.
Results: The average fluorescein load in SEDDS was 0.
045%.
SEDDS showed an average droplet size of 24.
9 ± 1.
6 nm with PDI ≤ 0.
3.
SEDDS complexes diluted 1:100 increased the zeta potential from -7.
3 mV to +3.
7 mV and provided > 85% cell viability.
A 92.
27 ± 3.
18% fluorescein exhibited a few seconds of immediate release when used as control or PEI complex in SEDDS.
On the contrary, Eudragit-fluorescein complexes in SEDDS showed sustained release of 87.
01 ± 5.
22% fluorescein in ≤ 70 min with 22.
19 ± 14.
56% and 59.
27 ± 16.
57% released at 10 min in pH 6.
8 and pH 8 release media, respectively.
Comparatively, the medium at pH 6.
8 maintained a significantly improved sustained fluorescein release (p ≤ 0.
001).
Furthermore, Eudragit RS/RL compared to Eudragit E, significantly exhibited a slower fluorescein release rate from SEDDS (p ≤ 0.
01).
The cellular uptake of the released fluorescein was 72.
4 ± 8.
2% for all SEDDS complexes after 3 h.
Eudragit complexes compared to PEI complex in SEDDS significantly showed m ore sustained fluorescein cellular uptake at 1 h and 2 h (p ≤ 0.
001).
However, SEDDS complexes showed the longest fluorescein stability with PEI after six months, whereas fluorescein stability for SEDDS containing fluorescein as Eudragit complex and control showed 39.
1% and 82.
5% fluorescence decrease, respectively, after three months.
Conclusion: In the developed SEDDS, the presence of hydrophobic ionic complexes can significantly promote longer stability and sustained cellular uptake of fluorescein while releasing in a sustained manner.

Related Results

Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin
Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin
The objective of this work was to design and characterize liquid and solid self-emulsifying drug delivery systems (SEDDS) for poorly soluble atorvastatin. To optimize the compositi...
The Technology of Self-Emulsifying Drug Delivery Systems
The Technology of Self-Emulsifying Drug Delivery Systems
Nearly 40% of novel chemical entities show evidence of low solubility in water and low bioavailability. Self-emulsifying formulations have showed the power to improve the bioavaila...
Preparation of Solid Self-Emulsifying Drug Delivery System of Manidipine Hydrochloride
Preparation of Solid Self-Emulsifying Drug Delivery System of Manidipine Hydrochloride
The ability of self-emulsifying drug delivery system (SEDDS), which is a mixture of oils, surfactants and co-surfactants, to improve dissolution rate of a poorly water-soluble drug...
Review article on self emulsifying system
Review article on self emulsifying system
The solubility challenges faced by the pharmaceutical industry, particularly with orally administered drugs, are indeed significant. Low aqueous solubility often leads to poor diss...
Enhanced Intestinal Permeability of Cefixime by Self-Emulsifying Drug Delivery System: In-Vitro and Ex-Vivo Characterization
Enhanced Intestinal Permeability of Cefixime by Self-Emulsifying Drug Delivery System: In-Vitro and Ex-Vivo Characterization
Background: Cefixime (CFX) belongs to a group of third-generation cephalosporin antibiotics with low water solubility and low intestinal permeability, which ultimately leads to sig...

Back to Top